These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
4. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627 [TBL] [Abstract][Full Text] [Related]
5. Dyslipidemias and fibrinolysis. Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815 [TBL] [Abstract][Full Text] [Related]
6. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects. von Känel R; Frey K; Fischer J Scand Cardiovasc J; 2004 Mar; 38(1):28-32. PubMed ID: 15204244 [TBL] [Abstract][Full Text] [Related]
7. Blood coagulation and fibrinolytic activity in hypothyroidism. Erem C; Kavgaci H; Ersöz HO; Hacihasanoglu A; Ukinç K; Karti SS; Deger O; Telatari M Int J Clin Pract; 2003 Mar; 57(2):78-81. PubMed ID: 12661786 [TBL] [Abstract][Full Text] [Related]
8. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation. Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in peripheral atherosclerosis in the elderly. van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006 [TBL] [Abstract][Full Text] [Related]
10. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men. Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793 [TBL] [Abstract][Full Text] [Related]
11. Negative correlation between D-dimer and plasminogen activator inhibitor-1 levels is absent in obese women. Ceo PT; Petruceli E; Bosco AA; Andrade-Fernandes CM; Russi CV; Carvalho Md; Sandrim VC Blood Coagul Fibrinolysis; 2012 Jul; 23(5):402-5. PubMed ID: 22527291 [TBL] [Abstract][Full Text] [Related]
12. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma. MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148 [TBL] [Abstract][Full Text] [Related]
13. Altered endothelial function following the Fontan procedure. Binotto MA; Maeda NY; Lopes AA Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358 [TBL] [Abstract][Full Text] [Related]
14. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease]. Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643 [TBL] [Abstract][Full Text] [Related]
15. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma. Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197 [TBL] [Abstract][Full Text] [Related]
16. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias. Zitoun D; Bara L; Basdevant A; Samama MM Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430 [TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy. Sattar N; Greer IA; Rumley A; Stewart G; Shepherd J; Packard CJ; Lowe GD Thromb Haemost; 1999 Jan; 81(1):71-5. PubMed ID: 9974378 [TBL] [Abstract][Full Text] [Related]
19. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus. Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573 [TBL] [Abstract][Full Text] [Related]
20. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA; Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]